NFKB1 and renal cell carcinoma: Studies performed on renal cell carcinoma demonstrated that AGE via NF-κB activation may favour tumour cell proliferation, apoptosis inhibition, increases the tumour angiogenesis ability and the potential of tumour cell invasion and metastasis (56).